News

FDA lifts hold on trial of SEL24 in AML

The US Food and Drug Administration (FDA) has lifted the clinical hold placed on a phase 1/2 trial of SEL24, a dual PIM/FLT3 kinase inhibitor, in...

Article

Once Retired, Now Just Tired

A 72-year-old man has experienced fatigue, lethargy, and shortness of breath for three weeks. Is he just "slowing down," or is there another...

Pages